Net Cash Provided by (Used in) Financing Activities in USD of PLIANT THERAPEUTICS, INC. from 2019 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
PLIANT THERAPEUTICS, INC. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2019 to Q1 2025.
  • PLIANT THERAPEUTICS, INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $498K, a 97.7% decline year-over-year.
  • PLIANT THERAPEUTICS, INC. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $23.1M, a 91.6% decline from 2023.
  • PLIANT THERAPEUTICS, INC. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $274M, a 21% increase from 2022.
  • PLIANT THERAPEUTICS, INC. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $227M, a 8877% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

PLIANT THERAPEUTICS, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $498K -$21.3M -97.7% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q1 2024 $21.8M -$252M -92% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q1 2023 $273M +$273M 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024
Q1 2022 -$153K -$1.52M -111% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q1 2021 $1.37M -$50.3M -97.4% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q1 2020 $51.7M 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021

PLIANT THERAPEUTICS, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $23.1M -$251M -91.6% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2025
2023 $274M +$47.6M +21% 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2025
2022 $227M +$224M +8877% 01 Jan 2022 31 Dec 2022 10-K 03 Mar 2025
2021 $2.53M -$211M -98.8% 01 Jan 2021 31 Dec 2021 10-K 27 Feb 2024
2020 $213M +$168M +368% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2022
2019 $45.5M 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.